Nanology Labs

Nanology Labs has developed a revolutionary non-toxic MRI contrast agent which circumvents efficacy limitations of other agents currently available. The agent, Manganescan™, uses the element manganese to illuminate early stage tumors, specifically in the brain. Early stage detection provides clinicians advance knowledge for diagnosis, better treatment options and patient outcome.

 

Nanology Labs Spotlight on Small Tumors

Nanology labs Inc., a UofT spin-off company, is a biotech/pharmaceutical startup, which designs and manufactures MRI contrast agent for brain tumor detection using MRI imaging.

 

 

Team Members

Mohammad Ali Amini
CEO and Co-Founder

Dr. Shirley Wu
CTO and Co-Founder

Sheila Quiroga
Business Development Coordinator